1.0hollandbiohttps://www.hollandbio.nl/en/rich600338<blockquote class="wp-embedded-content" data-secret="JQJMUqwVTC"><a href="https://www.hollandbio.nl/en/event-en/registries-reimagined/">Registries Reimagined</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.hollandbio.nl/en/event-en/registries-reimagined/embed/#?secret=JQJMUqwVTC" width="600" height="338" title="“Registries Reimagined” — hollandbio" data-secret="JQJMUqwVTC" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.hollandbio.nl/wp-includes/js/wp-embed.min.js </script> Regulators and pharmaceutical companies continue to incorporate real-world evidence (RWE) across all phases of drug development. Both the FDA and the EMA have shown an increased willingness to consider RWE, specifically with registry data when making regulatory decisions. Longitudinal, prospective registries have been conducted for decades, but never has there been a better opportunity for […]https://www.hollandbio.nl/wp-content/uploads/2023/03/registries.png